Sign up for free insights newsletter
BI

Bio-Rad Laboratories Inc

BIOUnited States

Need professional-grade analysis? Visit stockanalysis.com

$264.49
-1.31%
End of day
Market Cap

$7.05B

P/E Ratio

9.38

Employees

7,450

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.27-0.450.11-0.53-0.45
Calmar-1.91-0.490.12-0.19-0.47
Sharpe-1.08-0.330.07-0.38-0.36
Omega0.740.961.060.960.95
Martin-3.68-1.100.33-0.27-0.89
Ulcer11.0210.979.2251.8722.49

Bio-Rad Laboratories Inc (BIO) Price Performance

Bio-Rad Laboratories Inc (BIO) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $264.49, down 1.31% from the previous close.

Over the past year, BIO has traded between a low of $216.56 and a high of $339.75. The stock has gained 6.9% over this period. It is currently 22.2% below its 52-week high.

Bio-Rad Laboratories Inc has a market capitalization of $7.05B, with a price-to-earnings ratio of 9.38.

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$2.67B
EBITDA
$431.60M
Profit Margin
29.42%
EPS (TTM)
27.85
Book Value
276.16

Technical Indicators

52 Week High
$343.12
52 Week Low
$211.43
50 Day MA
$292.81
200 Day MA
$285.13
Beta
1.20

Valuation

Trailing P/E
9.38
Forward P/E
25.06
Price/Sales
2.73
Price/Book
0.95
Enterprise Value
$10.21B